Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity

The emergence and spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in significant global morbidity, mortality, and societal disruption. A better understanding of virus-host interactions may potentiate therapeutic insights toward limiting this infection. Here we inv...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoagland, Daisy A., Møller, Rasmus, Uhl, Skyler A., Oishi, Kohei, Frere, Justin, Golynker, Ilona, Horiuchi, Shu, Panis, Maryline, Blanco-Melo, Daniel, Sachs, David, Arkun, Knarik, Lim, Jean K., tenOever, Benjamin R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846242/
https://www.ncbi.nlm.nih.gov/pubmed/33577760
http://dx.doi.org/10.1016/j.immuni.2021.01.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846242/
https://www.ncbi.nlm.nih.gov/pubmed/33577760
http://dx.doi.org/10.1016/j.immuni.2021.01.017

Ejemplares similares